Furthermore, in breast cancer samples expressing high levels of both MR and RARB, the expression profile of these pro-glycolysis genes is closer to that observed in normal breast than in breast cancer, whereas in breast cancer samples expressing low levels of both MR and RARB, these pro-glycolysis genes are also expressed at a lower level than observed generally in breast cancer samples. The gene discussed is NR3C2; the disease is breast cancer.